Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study | News & Awards - China Medical University Hospital

Other Hospital CMUH APP icon

About CMUH

News and Award

:::

News and Award/

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

About CMUH

2/3/2026

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

回上頁

Related Articles

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer img

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer img

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

$INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer img$

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

Stay connected with CMUH

youtube

How to get to CMUH the map of hospital

Download

▲